| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |